Erlotinib Induced Trichomegaly of the Eyelashes / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
;
: 37-40, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-17410
ABSTRACT
Epithelial growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been widely used for non-small-cell lung cancer patients. Its untoward cutaneous effects are largely well known and developed in many patients treated with EGFR TKIs. However trichomegaly of eyelash is rarely reported. Although trichomegaly is not a drug-limiting side effect, it could be troublesome of continuing the treatment because of cosmetic issue or eyeball irritation by long eyelashes. Therefore clinicians are needed to pay attention to this uncommon effect. We herein describe erlotinib induced trichomegaly of eyelashes in a woman with adenocarcinoma of the lung.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Quinazolinas
/
Proteínas Tirosina Quinasas
/
Adenocarcinoma
/
Cosméticos
/
Efectos Fisiológicos de las Drogas
/
Pestañas
/
Receptores ErbB
/
Clorhidrato de Erlotinib
/
Pulmón
/
Neoplasias Pulmonares
Límite:
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Tuberculosis and Respiratory Diseases
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS